New Medicines Reviews 2013
Reports on the role of SMC & Review of IPTR & ADTC
Appendix 3
Monitoring implementation of SGHD/CMO(2012)1
April 2013
Contents
Appendix 1: Medicines approved by SMC April-September 2012
Appendix 2: Web search criteria
Appendix 3: Breakdown of NHS boards' ADTC decisions
Appendix 4: NHS board decisions for each medicine
Appendix 5: NHS board compliance per board for decision-making and timeliness
Appendix 6: CMO(2012)1 guidance example list of SMC medicines and formulary decisions
Contact
Email: VERONICA MOFFAT
There is a problem
Thanks for your feedback